Hydrogen Gas Shows Promise for Treating Lung Diseases and Breathing Problems
- Authors
- Dominika Zajac, Monika Jampolska, Piotr Wojciechowski
- Journal
- International Journal of Molecular Sciences
- Year
- 2025
- DOI
- 10.3390/ijms26094116
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- Poland
- Health Condition
- Asthma
- Body System
- Respiratory
TL;DR
Scientists found that a simple gas called molecular hydrogen might help treat lung diseases like asthma and bronchitis by reducing swelling and damage in the lungs—which is exciting because it could become a new medicine, but doctors need to do more testing to make sure it actually works.
Key Finding
Molecular hydrogen shows potential as a therapeutic agent with antioxidant, anti-inflammatory, and cell-protective properties across multiple respiratory diseases, though the evidence base remains primarily preclinical.
Summary
This review article summarized research from the past twenty years on how molecular hydrogen—a gas that was once thought to be biologically inactive—might help treat respiratory diseases like asthma, COPD (chronic obstructive pulmonary disease), pulmonary fibrosis, and lung infections. The authors describe how hydrogen may work in the body by reducing oxidative stress (cellular damage from unstable molecules), decreasing inflammation, and preventing cell death, and they conclude that these findings suggest hydrogen deserves further clinical testing.
Practical Takeaway
This is a review article summarizing existing research rather than a new clinical study, and it does not report results from human trials. While the summary suggests hydrogen's mechanisms are scientifically plausible, the authors themselves call for more clinical investigation—meaning evidence in actual patients is still limited. Anyone considering hydrogen water for respiratory conditions should understand that robust human evidence does not yet exist.
Abstract
Molecular hydrogen is gaining increasing attention as an antioxidant, anti-inflammatory, and antiapoptotic agent. Once considered an inert gas, it reveals current therapeutic potential among others in inflammatory diseases, cancer, and sports medicine, among others. The present review aims to provide a consistent summary of the findings of the last twenty years on the use of molecular hydrogen in major respiratory diseases, including allergies, asthma, COPD, pulmonary fibrosis, lung injury of various origins, as well as cancer and infections of the respiratory tract. In addition, the basic mechanisms through which molecular hydrogen exercises its biological activity on the respiratory system are described.